HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved intraoperative management of anastomotic bleeding during aortic reconstruction: results of a randomized controlled trial.

Abstract
In a randomized controlled trial, the effectiveness of a polymeric surgical sealant (CoSeal) was compared to Gelfoam/thrombin for managing anastomotic bleeding after implantation of Dacron grafts during aortic reconstruction for nonruptured aneurysms. Each treatment was directly applied to the suture line after confirmation of anastomotic bleeding. The proportion of suture line sites that achieved immediate sealing and the proportion sealed within 5 minutes were determined among 37 experimental (59 sites) and 17 control subjects (27 sites). A significantly greater proportion of bleeding suture line sites treated with the polymeric sealant achieved immediate sealing following reestablishment of blood flow compared with control-treated sites [48 of 59 (81%) vs 10 of 27 (37%); P = 0.002]. The difference between treatment groups was maintained after 5 minutes with approximately 85 per cent (50 of 59) of CoSeal sites compared to just over one-half (14 of 27) of control sites demonstrating ultimate sealing (P = 0.01). There were no adverse events related to the use of the polymeric sealant in this study. These results support the use of this novel sealant for the intraoperative management of anastomotic bleeding during aortic reconstruction procedures.
AuthorsRobert C Hagberg, Hazim J Safi, Joseph Sabik, John Conte, Jon E Block
JournalThe American surgeon (Am Surg) Vol. 70 Issue 4 Pg. 307-11 (Apr 2004) ISSN: 0003-1348 [Print] United States
PMID15098782 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • CoSeal
  • Polyethylene Terephthalates
  • Polyethylene Glycols
Topics
  • Adult
  • Aged
  • Anastomosis, Surgical (adverse effects)
  • Angiography
  • Aortic Aneurysm (pathology, surgery)
  • Blood Loss, Surgical (prevention & control)
  • Blood Vessel Prosthesis (adverse effects)
  • Female
  • Follow-Up Studies
  • Hemostasis, Surgical (methods)
  • Humans
  • Male
  • Middle Aged
  • Polyethylene Glycols (therapeutic use)
  • Polyethylene Terephthalates (therapeutic use)
  • Probability
  • Risk Assessment
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: